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A B S T R A C T   
Polydopamine nanoparticles (PD NPs) have been synthesized in the present work through the oxidative poly-
merization of dopamine in aqueous media containing five different types of alcohol in a constant solvent volume 
ratio. We have shown that the type of alcohol, along with the ammonium hydroxide concentration used in the 
synthesis process, conditions particle size. Additionally, it has been found that the type of alcohol employed 
influences the well-known capacity of polydopamine nanoparticles to adsorb iron. As a consequence, since a 
ferroptosis-like mechanism may account for the cytotoxicity of these nanoparticles, the type of alcohol could also 
have a determining role in their antineoplastic activity. Here, the existence of a correlation between the ability of 
polydopamine nanoparticles to load Fe3+ and their toxic effect on breast cancer cells has been proven. For 
instance, nanoparticles synthesized using 2-propanol adsorbed more Fe3+ and had the greatest capacity to reduce 
breast tumor cell viability. Moreover, none of the nanoparticle synthesized with the different alcohols signifi-
cantly decreased normal cell survival. Cancer cells present greater iron-dependence than healthy cells and this 
fact may explain why polydopamine nanoparticles toxicity, in which Fenton chemistry could be implicated, 
seems tumor-specific.   
1. Introduction 
Polydopamine, a synthetic melanin that made its way into materials 
Science as a coating agent [1], has begun to gain importance for cancer 
diagnosis and therapy [2]. Like natural melanins, which play an essen-
tial role in our organism by regulating the concentration of free metal 
cations [3,4], polydopamine has also shown to have a great affinity for 
such ions [5]. For this reason, nanoparticles synthesized with this 
polymer are being developed to create novel contrast agents for imaging 
techniques and new photothermal therapy systems [6,7]. 
Likewise, it has been observed that polydopamine nanoparticles (PD 
NPs) have intrinsic antineoplastic activity, and this property could be 
also related to their affinity for a metal cation: Fe3+. When internalized, 
PD NPs end up in lysosomes, the organelles that precisely store free 
cations in the cell, and it is though that, given their high Fe3+-loading 
capacity compared to that of other cations, they may be involved in a 
ferroptosis-like mechanism [8–10]. Thus, it is believed that PD NPs 
could adsorb lysosomal iron and cause an imbalance in the Fe2+/Fe3+
concentration that may propitiate an excessive generation of reactive 
oxygen species (ROS) through Fenton chemistry in cancer cells [11,12]. 
This fact would explain why when iron chelators or antioxidant com-
pounds are administered together with PD NPs the latter are not so 
cytotoxic and why the chelation of PD NPs with Fe increases their 
toxicity to tumor cells [8,9,13]. Moreover, as normal cells are not as 
dependent on iron as malignant cells [14,15], the PD-mediated ferrop-
tosis would not notably affect to their survival rate, as it has been 
already shown [8,9]. 
On the other hand, it is relevant to mention that most of these 
findings related to the cytotoxicity of PD NPs have been performed by 
synthetizing them in a basic aqueous medium containing ethanol, in 
which the self-polymerization of dopamine occurs [8]. It has been re-
ported that the use of alcohols in this chemical process can help to 
control PD NP size, which can range from tens to hundreds of nano-
meters by simply tuning the volume ratio of water to alcohol [10,12]. 
Among the different alcohols available, ethanol is the most frequently 
used possibly because it is completely miscible in water and is more 
polar than other types of alcohols [10,16]. Methanol and 2-propanol 
have also been employed to produce PD NPs [17]. However, the dif-
ferences caused in PD NPs by the use of different alcohols in their syn-
thesis have not been characterized and reported to date. 
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Therefore, in the present study, PD NPs have been synthesized in 
aqueous media containing water, ammonium hydroxide (NH4OH) and 
different alcohols (ROH), such as methanol (MeOH), ethanol (EtOH), 2- 
propanol (2-PrOH), 1-propanol (1-PrOH) and 2-methyl-2-propanol (2- 
Me-2-PrOH). The first aim was to analyze how the type of ROH and the 
water/ROH volume ratio employed, along with the concentration of 
NH4OH in the medium, influence particle size. In addition, since a 
ferroptosis-like mechanism may be responsible for PD NP toxicity to 
tumor cells, the Fe3+-loading capacity of the different PD(ROH) NPs 
produced has been also determined and compared. As a result, it has 
been shown that the type of ROH employed in PD NPs synthesis de-
termines their Fe3+-adsorption capacity and, consequently, their cyto-
toxicity, which has been determined for a breast cancer cell line (Fig. 1). 
A correlation between both properties has been found and besides, it has 
been observed that such relationship is reverse for normal cells. Finally, 
with the co-administration of deferoxamine (DFO) and glutathione 
(GSH) (an iron chelator and an antioxidant compound, respectively) 
together with the PD NPs [11,12], it has been corroborated that Fenton 
chemistry may mediate the production of ROS in treated tumor cells. 
2. Materials and methods 
2.1. Materials 
Dopamine hydrochloride, ammonium hydroxide, phosphate buff-
ered saline (PBS, 0.01 M, pH 7.4), DMEM medium, Fetal Bovine Serum 
(FBS), MTT reagent, L-glutathione reduced (GSH) and deferoxamine 
mesilate (DFO) were provided by Sigma-Aldrich. Penicillin-strepto-
mycin (5000 U/mL) was provided by Thermo Fisher Scientific. Iron (III) 
chloride anhydrous (FeCl3, 97 %), sodium acetate anhydrous, 1-propa-
nol (extra pure), 2-propanol (99.5 %) and 2-methyl-2-propanol (99.5 
%) were provided by Panreac. Absolute ethanol (99.5 %) and methanol 
(99.5 %) were supplied by VWR Chemicals. 
2.2. Methods 
IR absorption spectra were performed in a PerkinElmer Spec-
trumTwo™ spectrometer operating in the 4000− 400 cm− 1 wavelength 
range after preparing samples as pellets of PD NPs in potassium bromide. 
TEM images were acquired with a FEI Tecnai Spirit Twin at an accel-
eration voltage of 120 kV. PD NPs were dispersed in deionized water in a 
concentration less than 0.01 % (WT) and a drop of this dispersion was 
deposited on a copper grid with a collodion membrane and allowed to 
dry for 24 h. Hydrodynamic diameter of PD NPs was analyzed by dy-
namic light scattering (DLS) on the basis of their intensity-average size 
distribution with the Zetasizer Nano ZS90. PD NPs were suspended in a 
Trizma buffer (50 mM, pH 10) in a concentration less than 0.01 % (WT) 
and their translational diffusion coefficient was calculated using the 
Stokes-Einstein equation (Eq. (1)), where d(H) represents the hydrody-
namic diameter, D is the translational diffusion coefficient, k is the 
Boltzmann’z constant, T is absolute temperature and η is viscosity. 




Finally, the equipment used for the Fe3+ analysis was the Plasma 
Emission Spectrometer, model ULTIMA 2 of Jobin Yvon. The calibration 
range used was 10–100 ppm. 
2.2.1. Synthesis of polydopamine nanoparticles (PD NPs) 
The synthesis of the different PD NPs was carried out in a water (90 
mL)/ROH (40 mL) mixture, fixing the volume of the resulting solvent at 
140 mL in all cases. A NH4OH aqueous solution (28–30 %) was added to 
the water/ROH mixtures under magnetic stirring at 25 ◦C for 30 min, 
varying the concentration of NH4OH from 0.79 to 3.01 % (V/V) 
depending on the type of ROH. Finally, dopamine hydrochloride (0.5 g) 
was dissolved in deionized water (10 mL) and directly added to the 
mixed solution. All polymerization reactions were allowed to proceed 
Fig. 1. Scheme representing how the type of ROH employed in the synthesis of PD NPs may determine their tumor-specific toxicity. Since the ROH used seems to 
condition the ability of PD NPs to adsorb Fe3+ cations, it may determine the production of ROS in treated cancer cells through the Fenton chemistry. 
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for 24 h [16]. 
Once obtained, PD(ROH) NPs were isolated by centrifugation and 
purified by at least four centrifugation-redispersion cycles in deionized 
water. In order to calculate dopamine conversion rate, the resulting 
products were oven-dried at 105 ◦C until reaching a constant weight. 
2.2.2. Fe3+-loading capacity of the PD(ROH) NPs 
Fe3+-loaded PD(ROH) NPs were prepared by mixing approximately 1 
mL of PD NPs with 20 mL of a FeCl3 solution (acetate buffer, 0.4 M, pH 
4.5) at 25⁰C, in orbital shaking at 100 rpm overnight. Concentration and 
diameter (DLS) of NPs were: MeOH (2.4 mg/mL, 168 nm ± 43, PDI =
0.026); EtOH (2.4 mg/mL, 169 nm ± 37, PDI = 0.026); 2-PrOH (2.8 mg/ 
mL, 187 nm ± 37, PDI = 0.055); 1-PrOH (2.7 mg/mL, 190 nm ± 46, PDI 
= 0.044); and 2-Me-2-PrOH (3.9 mg/mL, 170 ± 47, PDI = 0.066). 
Different initial Fe3+ concentrations, from approximately 7–35 ppm, 
were studied for all PD(ROH) NPs. Then, loaded PD NPs were isolated by 
centrifugation and the Fe3+ content of the supernatant was determined 
by Inductively Coupled Plasma Atomic Emission Spectroscopy (ICP- 
AES). 
2.2.3. PD(ROH) NPs treatment for the cytotoxicity studies 
Isolated PD(ROH) NPs were purified by four centrifugation- 
resuspension cycles in deionized water for carrying out the cytotox-
icity studies. These PD NPs were later suspended in PBS (pH 7.4) with a 
final concentration and diameter (DLS) of approximately: i) MeOH (2.47 
mg/mL, 173.0 ± 51.3 nm, PDI = 0.067); ii) EtOH (1.76 mg/mL, 168.5 ±
40.7 nm, PDI = 0.034); iii) 2-PrOH (2.8 mg/mL, 188.0 ± 53.0 nm, PDI =
0.047); iv)1-PrOH (1.50 mg/mL, 176.3 ± 50.4 nm, PDI = 0.052); and v) 
2-Me-2-PrOH (1.94 mg/mL, 170.8 ± 53.7 nm, PDI = 0.077). 
2.2.4. Cell culture 
BT474 and HS5 cells were cultured at 37 ◦C in a humidified atmo-
sphere in the presence of carbon dioxide (CO2) (5 %). Culture medium 
(DMEM) was supplemented with FBS (10 %) and antibiotics (1 %) as 
instructed (ATCC, Wesel). 
2.2.5. Cytotoxicity studies 
To study the cytotoxicity of the PD(ROH) NPs, BT474 and HS5 were 
seeded in 24-well plates, with a density of 12,000 and 15,000 cells/mL 
respectively, and grown overnight with supplemented medium. The 
culture medium was replaced the following day with medium contain-
ing PBS (control) and five different concentrations (from 0.0074 mg/mL 
to 0.042 mg/mL) of the PD(ROH) NPs. In all cases, the cellular survival 
rate was analyzed for 72 h (EZ Reader 2000), and cellular viability was 
checked every 24 h through MTT assays, following a previously 
described protocol [8]. Each value shown is the average of three inde-
pendent experiments and the results obtained were considered statisti-
cally significant when p < 0.05. 
2.2.6. Effect of GSH and DFO on PD(ROH) NPs cytotoxicity 
With the purpose of testing whether the capacity of PD NPs to adsorb 
Fe3+ could be involved in their antiproliferative activity, additional MTT 
assays were performed using the BT474 cell line, seeding them in 24- 
well plates with at a density of 12,000 cells/mL [5,8,9]. After growing 
them overnight in supplemented medium, it was replaced the next day 
with medium containing: i) PBS (control); ii) DFO or GSH; iii) PD 
(MeOH) NPs; iv) PD(2-PrOH) NPs; v) PD(MeOH) NPs + DFO or GSH; 
and v) PD(2-PrOH) NPs + DFO or GSH. In all cases, the concentrations 
for PD(ROH) NPs, DFO and GSH were 0.029 mg/mL, 0.7 μM and 50 μM, 
respectively. The viability of the treated BT474 cells was studied again 
for 72 h, and the cellular survival rates were quantified every 24 h using 
the previously mentioned protocol [8]. Each result shown is again the 
average value of the three independent experiments. 
3. Results and discussion 
3.1. Effect of the different types of alcohols on the synthesis of PD NPs 
PD NPs were prepared using the standard procedure of oxidative 
polymerization of dopamine in a basic aqueous medium containing 
NH4OH and ROH. In order to study the effect that the type of ROH had 
on this chemical process, NP synthesis was performed with five different 
ROHs of 1, 2, 3 and 4 carbons. In all cases, the water/ROH volume ratio 
(10:4, 28.57 % (V/V)) and the NH4OH concentration (0.79 % V/V) were 
kept constant. Resulting PD(ROH) NPs were characterized by DLS and 
TEM and the values of the Hansen’s Solubility Parameters (HSP) dis-
tances (Ra values) between dopamine and all the water/ROHs mixtures 
were determined (Table 1). 
As can be seen, MeOH produced the largest NPs, followed by those 
produced using EtOH, 2-PrOH, 2-Me-2-PrOH and, finally, 1-PrOH. PD 
(ROH) NPs size, as determined by TEM, ranged from 382 ± 26 nm 
(MeOH) to 120 ± 16 nm (1-PrOH), which indicated that the higher the 
alcohol dielectric constant (ε), the greater the NP diameter and the 
polydopamine conversion yield. By contrast, PD NPs produced with 1- 
PrOH were smaller despite 1-PrOH having a high ε (20.1) [18]. The 
values for the hydrodynamic diameter obtained by DLS were higher than 
those obtained by TEM possibly due to the dehydration of the NPs that 
was necessary to perform to prepare the samples for microscopy, but 
followed the same trend in both cases [19]. Moreover, obtained NP 
polydispersity index (PDI) values were acceptable, and those lower than 
0.1 indicated that the PD(ROH) NPs were highly monodisperse [20]. 
According to the literature, the type of ROH used affects dopamine 
polymerization, being this effect explained by the HSP theory, in which 
Ra values refer to the three-dimensional distance between the solubility 
parameters of dopamine and the solvent (water/ROH mixtures) [18]. 
Thus, Jiang et al. had previously demonstrated that there is a relation-
ship between dopamine conversion yield and PD NP size, in turn 
conditioned by the water/ROH volume ratio employed. These authors 
calculated the Ra values among dopamine and three different water/-
ROH (EtOH, MeOH and 2-PrOH) solvent mixtures and reported that the 
smaller the Ra value, the higher the expected dopamine solubility and 
the higher the polymer conversion yield achieved. In addition, they also 
concluded that PD NPs can be more easily obtained in weakly alkaline 
water/ROH solvent mixtures with smaller Ra values [18]. 
In this way, the Ra values determined between dopamine and the 
five ROHs tested in this work showed that the water/ROH volume ratio 
(10:4, 28.57 % (V/V)) used was suitable for synthetizing PD NPs with 
MeOH, EtOH and 2-PrOH because the obtained values were close to the 
minimum Ra values reported by Jiang et al. [18]. However, when 
1-PrOH was used, the Ra value determined in this work (2.78) for the 
mentioned water/ROH ratio was far from being optimum. The optimal 
Ra value (8:6, 42.86 % (V/V)), with which a 297.5 ± 62.3 nm particle 
Table 1 
Size (TEM, DLS) of the PD NPs, conversion yield and Ra values of dopamine 
polymerization reaction as a function of the ROH employed.  
ROH ε TEM 
(nm) 
DLS (nm) Yield 
(%) 
Rac 
MeOH 33.1a 382 ± 26 628 ± 145 (PDI: 
0.229) 
22.0 4.21 
EtOH 23.8a 306 ± 32 412 ± 120 (PDI: 
0.075) 
17.8 3.06 
2-PrOH 19.2b 194 ± 20 282 ± 70 (PDI: 0.036) 14.6 2.82 
1-PrOH 20.1b 119 ± 16 191 ± 41 (PDI: 0.041) 5.4 2.78 
2-Me-2- 
PrOH 
12.47b 194 ± 27 286 ± 70 (PDI: 0.206) 13.0 3.13  
a [14]. 
b [18]. 
c The calculation used for obtaining the Ra values among dopamine and the 
ROH mixtures can be found in the Supplementary Material. 
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size was obtained, was found by varying the proportion of ROH in the 
solvent mixture from 35.71 % (V/V) to 50.0 % (V/V). Finally, regarding 
the use of 2-Me-2-PrOH, the Ra value obtained in this work (Ra = 3.13; 
28.57 % (V/V)) was also appropriate, since lower and higher ROH 
volume ratios (from 14.28 % to 21.43 % and 35.71 % (V/V)) led to 
obtain higher Ra values. All the steps taken in this work to determine the 
described Ra values can be consulted in the Supplementary Material 
(Tables S1–S4). 
Otherwise, in a second experiment, the effect of the NH4OH con-
centration on PD(ROH) NPs size was also studied. Fig. 2 and S1 show 
that for a fixed water/ROH volume ratio, the size of PD NPs could be 
altered by varying the concentration of NH4OH, whose main function in 
the synthesis process is to create a basic medium that allows 
polydopamine to be oxidized. 
In general, for all of the PD(ROH) systems studied, lower diameters 
were obtained by increasing the concentration of NH4OH, since the pH 
of the synthesis medium conditions PD oxidation and polymerization, as 
it had been previously demonstrated [19,21]. When the NH4OH con-
centration was set at 0.79 % (V/V), the smallest PD NPs (191 nm) were 
obtained using 1-PrOH and the largest (628 nm) using MeOH. Also, it 
was interesting to find that for 1-PrOH, the diameter of the NPs varied by 
290 nm when NH4OH concentration was increased from 0.79 to 1.19 % 
(V/V) and by 65 nm when the concentration increased from 1.19 to 1.58 
% (V/V). A similar behavior in size was found, based on the NH4OH 
concentration, for PD NPs obtained with MeOH and EtOH. The differ-
ence in their diameter when the NH4OH concentration was increased 
from 1.19 to 1.58 % (V/V) was 260 and 120 nm, respectively. However, 
when larger amounts of NH4OH were used, such difference was not so 
marked, similar to what was observed when 2-PrOH and 2-Me-2-PrOH 
were employed. Data corresponding to the PD(ROH) NPs diameter 
values as a function of the NH4OH concentration employed can be found 
in the Supplementary Material, too (Fig. S1F). 
Finally, in order to obtain PD(ROH) NPs smaller than 100 nm, which 
are interesting from a biomedical perspective [12,22], higher concen-
trations of NH4OH were tested. Fig. 3A shows the size of the PD NPs 
produced according to the type of ROH used and Fig. 3B–F shows the 
morphology of these PD(ROH) NPs smaller than 100 nm. 
3.2. Infrared characterization of PD(ROH) NPs 
IR spectroscopy has been widely used to characterize melanins [5,23, 
24]. Thus, main bands were here assigned according to the previous 
characterization of melanins and were the following: the broad ab-
sorption band with the maximum at 1612 cm− 1 may include the C=O 
stretching (non-carboxylic acid) and the C=C stretching of the aromatic 
system (at ca 1580 cm− 1). The N–H bending in an indole ring may 
Fig. 2. Hydrodynamic diameter (nm) of the PD(ROH) NPs as a function of the 
NH4OH concentration used in their synthesis with each water/ROH mixture. 
Fig. 3. Characterization of smaller PD(ROH) NPs: (A) Bar graph: Diameter vs. ROH and NH4OH concentration (inside bars) employed ; TEM images of PD(ROH) NPs, 
showing a mean size of (B) MeOH: 71.8 ± 12.4 nm, (C) EtOH: 71 ± 8.4 nm, (D) 2-PrOH: 91.1 ± 12.3 nm, (E)1-PrOH: 90.9 ± 12.5 and (F) 2-Me-2-PrOH: 91.5 ± 16 
nm. Scale bars are 200 nm in all cases. 
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appear at 1510 cm− 1, while the peaks at 1345 and 1383 cm− 1 may 
correspond to the C–N stretching mode of an indole and a pyrrole ring, 
respectively. The C–OH stretching in a phenol ring appears at 1280 
cm− 1. In the region from 4000 to 2000 cm− 1, the bands at 2956, 2922 
and 2840 cm− 1 correspond to the different vibrational modes of the 
aliphatic groups. The broad band placed at 3405 cm− 1 may include the 
-OH (phenol, carboxylic acid) and the -NH stretching modes (in an 
indole or in a primary amine). 
IR spectra of PD NPs obtained in the different water/ROH media are 
shown in Fig. 4. Spectra were normalized at 1580 cm− 1 in order to 
compare the intensity of the different bands. 
The above-described characteristic bands of melanins within the 
900− 1800 cm− 1 range can be seen in all PD(ROH) NPs. This is also the 
case within the 2700− 3700 cm− 1 range, but the relative intensity of the 
band at 3430 cm− 1 associated with -OH and -NH stretching modes 
notably decreased when either 1-PrOH, 2-PrOH or 2-Me-2-PrOH were 
used for PD NPs synthesis. 
3.3. Influence of the use of different alcohols on PD NPs Fe3 +-adsorption 
capacity 
Here, the Fe3+-adsorption capacity of the PD(ROH) NPs was studied. 
First, changes in the morphology of PD(EtOH) NPs upon interaction with 
two initial Fe3+ concentrations (30 and 70 ppm) were evaluated. TEM 
image in Fig. 5A shows a control of unloaded PD NPs, while the slight 
variation in the morphology of Fe3+-loaded NPs can be observed in 
Fig. 5B–C, especially when the initial Fe3+ concentration was higher, 
since the NPs seem to be spongier. 
Then, PD(ROH) NP Fe3+-loading capacity was further analyzed, 
fitting the equilibrium results using the Freundlich isotherm, which is 
applied in multilayer adsorption processes on heterogeneous surfaces 
[25,26]. The initial Fe3+ concentration added varied in the range of 
7− 35 ppm at pH 4.5, while the concentration of the PD NPs was kept 
constant to allow for proper comparisons. TEM images of the NPs used to 
obtain the isotherms can be found in the Supplementary Material 
(Fig. S2). As a result, it was shown that all PD(ROH) NPs were able to 
adsorb this metal cation, which made their surface spongier; a fact that 
was in accordance with what had already been reported in the literature 
[11]. Nevertheless, according to the equilibrium results, Fe3+-loading 
capacity varied depending on the water/ROH synthesis mixture 
employed. This difference was more accentuated when a higher Fe3+
concentration (35 ppm) was used, while the difference in the adsorption 
capacity of the PD(ROH) NPs was negligible for a lower concentration (7 
ppm). PD NPs prepared in 2-PrOH showed the highest absorption ca-
pacity of Fe3+ with respect to the other PD(ROH) systems and, by 
contrast, PD(2-Me-2-PrOH) NPs were clearly the NPs with the lowest 
Fe3+-adsorption capacity. Linear fittings according to Freundlich model, 
Fe3+-adsorption efficiency (%) and fitted parameters (1/n and Q) can 
also be consulted in the Supplementary Material (Fig. S3 and Table S4). 
3.4. Cytotoxicity of the different PD(ROH) NPs 
In this section, the cytotoxicity of the PD(ROH) NPs synthetized was 
analyzed. Previously, it had been reported that standard PD(EtOH) NPs 
were intrinsically toxic to cancer cells, especially to the breast carci-
noma cell line BT474 [5,8,9]. For this reason, this human cell line was 
chosen to study the antitumor effect of the different PD(ROH) NPs 
produced in this work. Likewise, the stromal HS5 cell line was selected 
Fig. 4. IR spectra in the 900–1800 cm− 1 range (A) and in the 2700-3700 cm-1 range (B) for all the PD(ROH) NPs.  
Fig. 5. TEM images of PD(EtOH) NPs: (A) unloaded (105.7 ± 14.4 nm), (B) after interacting with 30 ppm of Fe3+ (95.1 ± 13.3 nm) and (C) after interacting with 70 
ppm of Fe3+(97.8 ± 14.0 nm). Scale bars are 100 nm. 
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for comparing PD(ROH) NPs toxicity to tumor and normal cells. The 
results of the viability assays carried out on both cell lines, treated with 
different concentrations of the PD(ROH) NPs, can be found in Fig. 6 
(BT474 cells) and in Fig. 7 (HS5 cells). Additionally, a table with the 
survival rates (%) corresponding to these figures can be found in the 
Supplementary Material (Fig. S5). 
As shown in Fig. 6, the PD(ROH) NPs caused, in all cases, a notable 
reduction in the viability of BT474 cells. This result was especially 
apparent 72 h after the cells were treated with the highest concentra-
tions of NPs (0.035 mg/mL and 0.042 mg/mL). Among the different 
types of PD NPs, those synthesized using MeOH, EtOH and 1-PrOH 
exhibited practically the same level of cytotoxicity. It was observed 
that these PD NPs were able to reduce the rate of cell survival by 20–25 
% 24 h after treatment with NP concentrations of 0.035 mg/mL and 
0.042 mg/mL. However, the survival rate of these cells was slightly 
higher when they were treated with the same concentrations of PD(2- 
Me-2-PrOH) NPs, and even more when PD(2-PrOH) NPs were adminis-
tered. Nevertheless, this pattern changed once 48 and 72 h elapsed. After 
such time, the highest concentrations of PD(MeOH), PD(EtOH) and PD 
(1-PrOH) NPs used reduced cellular viability by around 30–40 %, 
while cell treatment with PD(2-Me-2-PrOH) NPs caused a viability 
reduction of 25–30 %. However, the cytotoxicity of the PD(2-PrOH) NPs 
was more marked, where BT474 cell survival rate was reduced to 
approximately half. In addition, it was observed that for the other PD 
(ROH) NP concentrations, the behavior was similar to that described for 
the highest concentrations, although their antitumor effect was not as 
marked. 
Also, no significant reduction in HS5 cell viability was found for any 
of the PD(ROH) NPs (Fig. 7). In all cases, the rates of cellular survival 
were higher than 82 % 72 h after treatment with the highest NP 
Fig. 6. Results of the MTT assay performed on the BT474 cell line treated with five different concentrations of PD(ROH) NPs. ROH = (A) MeOH, (B) EtOH, (C) 2- 
PrOH, (D) 1-PrOH and (E) 2-Me-2-PrOH. The results shown represent the mean ± standard deviation of three replicas done for each treatment. 
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concentrations, except when treatment was performed with PD(EtOH) 
NPs, which were the most toxic to stromal cells. When comparing the 
viability percentages of both BT474 and HS5 cell lines, treated with the 
same concentrations of NPs, greater differences were found after 72 h, 
the time point when PD NPs antitumor activity was the highest. Taking 
into account the results obtained, it should be mentioned that the less 
selective NPs were the ones prepared in 2-Me-2-PrOH, while the NPs 
with the most selective antitumor activity were the PD(2-PrOH) NPs. 
As shown, PD(2-PrOH) NPs were the NPs that decreased BT474 
cellular viability the most (to 53 % after 72 h of the treatment with a 
0.042 mg/L concentration) and had the most noticeable Fe3+-adsorption 
capacity (140 mg/g for Ci =35 ppm). Conversely, PD(2-Me-2-PrOH) NPs 
exhibited the lowest Fe3+-adsorption efficiency and had the lowest 
ability to reduce the survival rate of the BT474 cells (reduced to 73 % 
after 72 h of treatment with a the highest concentration). This relation 
between Fe3+-loading and BT474 cell toxicity was also similar for all of 
the other PD(ROH) NPs, except for the PD(EtOH) NPs, with which 
similar results were obtained to those that had already been reported [8, 
9]. As a result, a linear correlation could be established between both 
properties (Fig. S6). Also, this relation seemed to be inverse for HS5 
cells, where a lower Fe3+-adsorption capacity of PD NPs was accompa-
nied by a higher toxicity to stromal cells. 
Iron is an essential element for most organisms, with a fundamental 
role for cell growth and proliferation. However, as mentioned in the 
introduction, iron can also be implicated in the generation of reactive 
oxygen species (ROS) through its participation in Fenton’s chemistry, 
triggering cell death [11,15,27]. For this reason, it was believed that PD 
Fe3+-adsorption capacity could be related to PD(ROH) NPs 
tumor-specific toxicity and to verify this fact, additional viability assays 
were carried out, where breast cancer cells were co-treated with DFO or 
Fig. 7. Results of the MTT assays performed on the HS5 stromal cell line treated with five different concentrations of (A) PD(MeOH), (B) PD(EtOH), (C) PD(2-PrOH), 
(D) PD(1-PrOH) and (E) PD(2-Me-2-PrOH) NPs. The results shown represent the mean ± standard deviation of the three replicas done for each treatment. 
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GSH. 
3.5. Antiproliferative effect of PD(ROH) NPs on cancer cells Co-treated 
with DFO or GHS 
In order to show that the Fe3+-adsorption capacity of PD(ROH) NPs 
could be involved in their tumor-selective toxicity, BT474 cells were co- 
treated with PD(MeOH, EtOH and 2-PrOH) NPs and with non-toxic 
concentrations of DFO and GHS. These three types of PD(ROH) NPs 
were the ones selected to perform further viability assays because they 
presented greater anticancer activity. Also, DFO and GHS were chosen 
because they are an iron-chelating compound and an antioxidant agent, 
respectively [28,29]. Thus, additional MTT assays were carried out, 
studying BT474 cellular viability 24, 48 and 72 h after the aforemen-
tioned co-treatment [8]. As shown in Fig. S7, it could be seen that such 
co-treatment managed to partially block the antiproliferative activity of 
PD(ROH) NPs, since the cellular survival rate was on average higher 
than 80 %. Major differences between the cytotoxicity of the treatment 
with PD(ROH) NPs or with PD(ROH) NPs plus DFO or GSH could again 
be noticed after 72 h and were greater when BT474 cells were treated 
with PD(2-PrOH) NPs. 
Consequently, it was found that the Fe3+-loading of the PD NPs could 
account for their antitumor effect. Thus, when these NPs are internalized 
and end up in cellular lysosomes [8], they could cause an imbalance 
between the oxidized and reduced free iron forms and mediate an 
enhanced production of ROS through the Fenton reaction. In addition, 
since cancer cells have a greater iron-dependence than normal cells [14, 
15], the viability of the latter was not so reduced by the PD NPs cyto-
toxicity mediated by their Fe3+-loading capacity. 
4. Conclusions 
Throughout the present study it was shown that MeOH, EtOH, 2- 
PrOH, 1-PrOH and 2-Me-2-PrOH can all be used to synthetize PD NPs, 
which size depended on the type of ROH used. Generally, the lower the ε 
of the ROH, the smaller the PD NP diameter, which also depended on the 
NH4OH concentration used in the synthesis process. With regard to the 
latter, the higher the concentration of NH4OH added, the smaller the 
size of the NPs produced. 
In addition, it has also been proven that Fe3+-loading capacity of PD 
NPs was determined by the ROH used in their synthesis. Since a 
ferroptosis-like mechanism may account for PD NP cytotoxicity, the 
ROH used may also influence the final outcome. Cancer cells present 
great dependence on iron and, for this reason, PD NPs that are more 
efficient at adsorbing Fe3+ may cause a greater imbalance in the con-
centration of their lysosomal Fe2+ and Fe3+ when they are endocyted 
and propitiate an increase in ROS production. This fact would help to 
explain why PD(2-PrOH) NPs, the ones with a higher Fe3+-adsorption 
capacity, were the NPs that most reduced the survival rate of breast 
cancer cells. Finally, this fact could also explain why PD NP toxicity was 
partially reduced when cells were co-treated with an iron chelator or an 
antioxidant compound. Moreover, since non-tumor cells are not that 
iron-dependent, the ferroptosis-like mechanism mediated through PD 
NPs may shed light on why such NPs did not significantly reduce their 
viability. 
Therefore, based on the results presented here, it is clear that PD NPs, 
especially those prepared using 2-PrOH, may play an important role in 
the development of future and novel cancer therapy strategies. 
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